158 related articles for article (PubMed ID: 38866752)
21. Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion.
Zhang X; Groen K; Morten BC; Steffens Reinhardt L; Campbell HG; Braithwaite AW; Bourdon JC; Avery-Kiejda KA
Mol Oncol; 2022 Jan; 16(2):447-465. PubMed ID: 34657382
[TBL] [Abstract][Full Text] [Related]
22. The role of p53 in cancer drug resistance and targeted chemotherapy.
Hientz K; Mohr A; Bhakta-Guha D; Efferth T
Oncotarget; 2017 Jan; 8(5):8921-8946. PubMed ID: 27888811
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in validating MDM2 as a cancer target.
Rayburn ER; Ezell SJ; Zhang R
Anticancer Agents Med Chem; 2009 Oct; 9(8):882-903. PubMed ID: 19538162
[TBL] [Abstract][Full Text] [Related]
24. Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf
Chapeau EA; Gembarska A; Durand EY; Mandon E; Estadieu C; Romanet V; Wiesmann M; Tiedt R; Lehar J; de Weck A; Rad R; Barys L; Jeay S; Ferretti S; Kauffmann A; Sutter E; Grevot A; Moulin P; Murakami M; Sellers WR; Hofmann F; Jensen MR
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3151-3156. PubMed ID: 28265066
[TBL] [Abstract][Full Text] [Related]
25. Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.
Kim TH; Leslie P; Zhang Y
Oncotarget; 2014 Feb; 5(4):860-71. PubMed ID: 24658219
[TBL] [Abstract][Full Text] [Related]
26. The p53 isoforms are differentially modified by Mdm2.
Camus S; Ménendez S; Fernandes K; Kua N; Liu G; Xirodimas DP; Lane DP; Bourdon JC
Cell Cycle; 2012 Apr; 11(8):1646-55. PubMed ID: 22487680
[TBL] [Abstract][Full Text] [Related]
27. Alternative and aberrant splicing of MDM2 mRNA in human cancer.
Bartel F; Taubert H; Harris LC
Cancer Cell; 2002 Jul; 2(1):9-15. PubMed ID: 12150820
[TBL] [Abstract][Full Text] [Related]
28. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
29. The Balance between p53 Isoforms Modulates the Efficiency of HIV-1 Infection in Macrophages.
Breton Y; Barat C; Tremblay MJ
J Virol; 2021 Sep; 95(20):e0118821. PubMed ID: 34379507
[TBL] [Abstract][Full Text] [Related]
30. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
[TBL] [Abstract][Full Text] [Related]
31. Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
Inoue K; Fry EA
Int J Cancer; 2016 Jul; 139(1):33-41. PubMed ID: 26802432
[TBL] [Abstract][Full Text] [Related]
32. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
33. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
34. IRES mediated translational regulation of p53 isoforms.
Sharathchandra A; Katoch A; Das S
Wiley Interdiscip Rev RNA; 2014; 5(1):131-9. PubMed ID: 24343861
[TBL] [Abstract][Full Text] [Related]
35. A Numb-Mdm2 fuzzy complex reveals an isoform-specific involvement of Numb in breast cancer.
Colaluca IN; Basile A; Freiburger L; D'Uva V; Disalvatore D; Vecchi M; Confalonieri S; Tosoni D; Cecatiello V; Malabarba MG; Yang CJ; Kainosho M; Sattler M; Mapelli M; Pece S; Di Fiore PP
J Cell Biol; 2018 Feb; 217(2):745-762. PubMed ID: 29269425
[TBL] [Abstract][Full Text] [Related]
36. Transcription factors that interact with p53 and Mdm2.
Inoue K; Fry EA; Frazier DP
Int J Cancer; 2016 Apr; 138(7):1577-85. PubMed ID: 26132471
[TBL] [Abstract][Full Text] [Related]
37. Mdmx promotes genomic instability independent of p53 and Mdm2.
Carrillo AM; Bouska A; Arrate MP; Eischen CM
Oncogene; 2015 Feb; 34(7):846-56. PubMed ID: 24608433
[TBL] [Abstract][Full Text] [Related]
38. p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies.
Horvat A; Tadijan A; Vlašić I; Slade N
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207603
[TBL] [Abstract][Full Text] [Related]
39. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
40. p53 Isoform Delta113p53 in zebrafish.
Chen J; Peng J
Zebrafish; 2009 Dec; 6(4):389-95. PubMed ID: 19916829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
